Effects of aspirin combined with ticagrelor or clopidogrel on stent thrombosis in coronary bifurcation lesions

Effects of aspirin combined with ticagrelor or clopidogrel on stent thrombosis in coronary bifurcations

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025059

Enrollment

Unknown

Registered

2019-08-09

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary bifurcation lesions

Interventions

1:aspirin combined with ticagrelor

2:aspirin combined with clopidogrel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with coronary bifurcation lesions undergoing PCI; 2. Aged 18 to 90 years; 3. Administrated with dual antiplatelet therapy; 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications to dual antiplatelet therapy; 2. Treated with anticoagulant; 3. Intraoperative deaths; 4. Abnormality of platelet count and function; 5. Expected survival period of less than 1 year in the history of malignancy; 6. There are any other factors in the study that are not suitable for inclusion in the study or affect the subject's participation in or completion of the study.

Design outcomes

Primary

Measure	Time frame
major adverse cardiovascular event;	—

Secondary

Measure	Time frame
stent thrombosis;myocardial infarction;death;stroke;	—

Countries

China

Contacts

Public ContactXiaohui Zhao

The Second Affiliated Hospital of Army Medical University

doctorzhaoxiaohui@yahoo.com+86 023-68774001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026